![]() |
Large Medium Small |
Wu and his team developed state-of-the-art methods to help correct disordered metabolisms for patients in the post-surgery period.
The methods has helped numerous patients to resume their lives.
![]() Wu Mengchao. [Xinhua] |
It has various causes, forms and complications, including hepatitis, liver failure and hepatic necrosis.
Millions of families in the country are exposed to liver diseases, since some types are epidemic.
Wu's efforts in treating patients with advanced liver cancer have earned him a worldwide reputation.
The introduction of the "second phase operation" method to alleviate pain was adopted by others in the field.
The survival rate in a five-year span after surgery has improved from 16 per cent during 1960s-70s, to 30.6 per cent in 1989 and nearly 50 per cent in 1990.
During his 40 years of medical practice, Wu has conducted more than 8,000 cancer removing operations, with the survival rate at 38.1 per cent.
More than 1,000 other patients with smaller tumours have gained a much greater chance for survival after surgical treatment by Wu, with 80 per cent living for more than five years. .
One patient even lived for another 36 years in his post-operation time.
By 1986, Wu had carried out 1,019 operations for hepatic lobe removals in liver surgery and 97 per cent were successful.
His work led to the establishment of the world's largest hepatopath research and healing centre.
Wu's stacks of academic papers and compiled books served to train the followers in the field.
Wu was named The Academician of Chinese Academy of Sciences in 1991.